We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

147 hedge funds and large institutions have $453M invested in Avid Bioservices, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 50 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 10

333% more call options, than puts

Call options by funds: $1.39M | Put options by funds: $320K

94% more capital invested

Capital invested by funds: $234M → $453M (+$219M)

67% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 30

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

32% more funds holding

Funds holding: 111147 (+36)

Holders
147
Holders Change
+36
Holders Change %
+32.43%
% of All Funds
2.6%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
46
Increased
50
Reduced
30
Closed
10
Calls
$1.39M
Puts
$320K
Net Calls
+$1.06M
Net Calls Change
+$858K
Name Holding Trade Value Shares
Change
Change in
Stake
VBCG
151
Valley Brook Capital Group
Pennsylvania
+$530 +58 New

CDMO Hedge Fund Activity: Q4 2020 in Review

147 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2020, worth a combined $453M — up 94% from $234M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CDMO positions and 10 closed out — a net gain of 36 holders — while 50 added to existing stakes and 30 trimmed.

The largest buyer was Kornitzer Capital Management, opening a new position worth an estimated $9.46M. The largest seller was Millennium Management, cutting an estimated $18.5M.

  • 147 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2020, up from 111 in Q3 2020.
  • Funds reported $453M of Avid Bioservices, Inc. Common Stock stock for Q4 2020, up 94% quarter-over-quarter.
  • 46 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +36 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2020 was Kornitzer Capital Management, an estimated $9.46M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2020 was Millennium Management, an estimated $18.5M sold.

Based on aggregated 13F filings for Q4 2020.